CFTR and cystic fibrosis: Cystic fibrosis (CF) lung disease is the main cause of mortality and morbidity in patients with CF for whom the emergence of effective mucolytic, anti-infective and causal cystic fibrosis transmembrane conductance regulator (CFTR) modulating therapies has markedly increased disease prospects (1, 2).